137 related articles for article (PubMed ID: 28572795)
1. Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant
Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Yu WL; Chen HJ; Chiu YH; Ko WC; Chuang YC
Front Microbiol; 2017; 8():884. PubMed ID: 28572795
[TBL] [Abstract][Full Text] [Related]
2. The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An in Vitro Study.
Lai CC; Chen CC; Lu YC; Lin TP; Chen HJ; Su BA; Chao CM; Chuang YC; Tang HJ
Antibiotics (Basel); 2019 Oct; 8(4):. PubMed ID: 31615078
[TBL] [Abstract][Full Text] [Related]
3. Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.
Lai CC; Chen CC; Chuang YC; Tang HJ
Sci Rep; 2017 Jan; 7():41758. PubMed ID: 28139739
[TBL] [Abstract][Full Text] [Related]
4. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
5. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
Matsuo K; Uete T
Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
[TBL] [Abstract][Full Text] [Related]
6. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. I. Effect of NaCl.
Uete T; Matsuo K
Jpn J Antibiot; 1995 Apr; 48(4):553-62. PubMed ID: 7783318
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
Matsuo K; Uete T
Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
[TBL] [Abstract][Full Text] [Related]
9. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India.
Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK
J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.
Smith JR; Arya A; Yim J; Barber KE; Hallesy J; Singh NB; Rybak MJ
Antimicrob Agents Chemother; 2016 Jul; 60(7):3970-5. PubMed ID: 27090172
[TBL] [Abstract][Full Text] [Related]
11. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
12. Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of
Kebriaei R; Rice SA; Stamper KC; Rybak MJ
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670436
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.
Vaudaux P; Huggler E; Arhin FF; Moeck G; Renzoni A; Lew DP
Int J Antimicrob Agents; 2009 Dec; 34(6):540-3. PubMed ID: 19744838
[TBL] [Abstract][Full Text] [Related]
14. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
[TBL] [Abstract][Full Text] [Related]
15. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC
BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468
[TBL] [Abstract][Full Text] [Related]
17. A 5-year Survey Reveals Increased Susceptibility to Glycopeptides for Methicillin-Resistant
Jiang B; Yin S; You B; Huang G; Yang Z; Zhang Y; Chen Y; Chen J; Yuan Z; Rao X; Hu X; Gong Y; Peng Y
Front Microbiol; 2017; 8():2531. PubMed ID: 29312223
[TBL] [Abstract][Full Text] [Related]
18. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Farrell DJ; Flamm RK; Sader HS; Jones RN
Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
Xhemali X; Smith JR; Kebriaei R; Rice SA; Stamper KC; Compton M; Singh NB; Jahanbakhsh S; Rybak MJ
J Antimicrob Chemother; 2019 Jan; 74(1):82-86. PubMed ID: 30260409
[TBL] [Abstract][Full Text] [Related]
20. Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006-2011 in China.
Zhuo C; Xu YC; Xiao SN; Zhang GY; Zhong NS
Int J Antimicrob Agents; 2013 Jun; 41(6):578-81. PubMed ID: 23562222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
